Assessing the Safety and Efficacy of PLB1004 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT05347628 · UNKNOWN
Trial details
- NCT number
- NCT05347628
- Sponsor
- Avistone Biotechnology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-25
- Primary completion
- 2023-04-04
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.